We are working with one of the world’s largest biotech companies to re-implement a complex mathematical model for the trafficking of CAR T-cells, converting C and Python code into high-performance software.
We are using our Evidence platform to make the code more accessible and reusable and providing training to their modelling team on how to get the most out of the converted model.